Zdrowie i gospodarka · 07/08/2023

FDA Releases Final Guidance on Nitrosamine Drug Substance-Related Impurities

The FDA has released a final guidance for industry on recommended acceptable intake limits for nitrosamine drug substance-related impurities, providing a framework for predicting mutagenic and carcinogenic potential and recommending limits for manufacturers and applicants.